On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Alexa B. Schrock

ResearcherPublications, citations & collaboration network

Alexa B. Schrock is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Alexa B. Schrock have?

ScholarIQindexed works

Alexa B. Schrock has 877 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Alexa B. Schrock have?

ScholarIQcitation count

Alexa B. Schrock has 17,844 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Alexa B. Schrock?

ScholarIQh-index

Alexa B. Schrock has an h-index of 60 in OpenAlex.

What is the i10-index of Alexa B. Schrock?

ScholarIQi10-index

Alexa B. Schrock has an i10-index of 157 in OpenAlex.

What is the ORCID of Alexa B. Schrock?

ScholarIQorcid

The ORCID for Alexa B. Schrock is on the source record.

What is the OpenAlex record for Alexa B. Schrock?

ScholarIQopenalex

The OpenAlex for Alexa B. Schrock is on the source record.

What are the most-cited papers on Alexa B. Schrock?

ScholarIQmost cited works
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers, Caitlin Connelly, David Fabrizio, Laurie M. Gay, Siraj M. Ali, Riley Ennis, Alexa B. Schrock, Brittany Campbell, Adam Shlien, Juliann Chmielecki, Franklin W. Huang, Yuting He, James Sun, Uri Tabori, Mark Kennedy, Daniel S. Lieber, Steven Roels, Jared White, Geoffrey A. Otto, Jeffrey S. Ross, Levi A. Garraway, Vincent A. Miller, P. J. Stephens, Garrett M. Frampton
Genome Medicine. 20173,771 CitationsOPEN ACCESS
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma
Ferdinandos Skoulidis, Michael E. Goldberg, Danielle Greenawalt, Matthew D. Hellmann, Mark M. Awad, Justin F. Gainor, Alexa B. Schrock, Ryan J. Hartmaier, Sally E. Trabucco, Laurie M. Gay, Siraj M. Ali, Julia A. Elvin, Gaurav Singal, Jeffrey S. Ross, David Fabrizio, Péter M. Szabó, Chang Han, Ariella Sasson, Sujaya Srinivasan, Stefan Kirov, Joseph D. Szustakowski, Patrik Vitazka, Robin Edwards, José A. Bufill, Neelesh Sharma, Sai‐Hong Ignatius Ou, Nir Peled, David R. Spigel, Hira Rizvi, Elizabeth Jiménez Aguilar, Brett W. Carter, Jeremy Erasmus, Darragh Halpenny, Andrew J. Plodkowski, Niamh M. Long, Mizuki Nishino, Warren L. Denning, Ana Galán‐Cobo, Haïfa Hamdi, Taghreed Hirz, Pan Tong, Jing Wang, Jaime Rodriguez‐Canales, Pamela Villalobos, Edwin R. Parra, Neda Kalhor, Lynette M. Sholl, Jennifer L. Sauter, Achim A. Jungbluth, Mari Mino–Kenudson, Roxana Azimi, Yasir Y. Elamin, Jianjun Zhang, Giulia C. Leonardi, Fei Jiang, Kwok‐Kin Wong, J. Jack Lee, Vassiliki A. Papadimitrakopoulou, Ignacio I. Wistuba, Vincent A. Miller, Garrett M. Frampton, Jedd D. Wolchok, Alice T. Shaw, Pasi A. Jänne, Philip J. Stephens, Charles M. Rudin, William J. Geese, Lee A. Albacker, John V. Heymach
Cancer Discovery. 20181,635 CitationsOPEN ACCESS
Structure-based classification predicts drug response in EGFR-mutant NSCLC
Jacqulyne Robichaux, Xiuning Le, R. S. K. Vijayan, J. Kevin Hicks, Simon Heeke, Yasir Y. Elamin, Heather Lin, Hibiki Udagawa, Ferdinandos Skoulidis, Hai T. Tran, Susan Varghese, Junqin He, Fahao Zhang, Monique B. Nilsson, Lemei Hu, Alissa Poteete, Waree Rinsurongkawong, Xiaoshan Zhang, Chenghui Ren, Xiaoke Liu, Lingzhi Hong, Jianjun Zhang, Lixia Diao, Russell W. Madison, Alexa B. Schrock, Jennifer Saam, Victoria M. Raymond, Bingliang Fang, Jing Wang, Min Jin Ha, Jason B. Cross, Jhanelle E. Gray, John V. Heymach
Nature. 2021470 CitationsOPEN ACCESS
Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations
Alexa B. Schrock, Garrett M. Frampton, James Suh, Zachary R. Chalmers, Mark R. Rosenzweig, Rachel Erlich, Balázs Halmos, Jonathan W. Goldman, Patrick M. Forde, Kurt Leuenberger, Nir Peled, Gregory P. Kalemkerian, Jeffrey S. Ross, Philip J. Stephens, Vincent A. Miller, Siraj M. Ali, Sai‐Hong Ignatius Ou
Journal of Thoracic Oncology. 2016384 CitationsOPEN ACCESS
Receptor Tyrosine Kinase Fusions and BRAF Kinase Fusions are Rare but Actionable Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors
Alexa B. Schrock, Viola W. Zhu, Wen-Son Hsieh, Russell W. Madison, Ben Creelan, Jeffrey Silberberg, Dan Costin, Anjali Bharne, Ioana Bonta, Thangavijayan Bosemani, Petros Nikolinakos, Jeffrey S. Ross, Vincent A. Miller, Siraj M. Ali, Samuel J. Klempner, Sai‐Hong Ignatius Ou
Journal of Thoracic Oncology. 2018137 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account